LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease Michael Hufford Eric Lagasse #liver #clinicaltrial #ESLD #regenerativemedicine #lymphnodes https://lnkd.in/eKkRpKup
About us
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other therapeutic targets for organ regeneration include the thymus, pancreas, and kidney. Privately held, LyGenesis is headquartered in Pittsburgh, Pennsylvania. To learn more, please visit our website at www.lygenesis.com.
- Website
-
https://www.lygenesis.com
External link for LyGenesis
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Pittsburgh, Pennsylvania
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
Get directions
Shady Ave
Pittsburgh, Pennsylvania, US
Employees at LyGenesis
Updates
-
Thank you LifeX for featuring LyGenesis!
Don't miss out on another amazing HealthTech Startup Sparks tomorrow with LyGenesis!!! Register now at: https://lnkd.in/efibGTBg
-
-
LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab https://lnkd.in/dh9FSN3U
LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab
prnewswire.com
-
An endoscopic ultrasound procedure combines two kinds of technology: Endoscopy, which uses a thin, flexible tube with a camera and a light on the end. Ultrasound, which uses high-frequency sound waves to create detailed pictures of internal organs. #drugdevelopment #drugresearch #organdonor #liverdisease #liverfailure #science
-
We are constantly working on improving peoples way of life, and giving hope to those on the transplant list, and some who in the past may not have qualified at all for a transplant. #liverfailure #organtransplant #drugdevelopment #biotech #investment #organdonor #science #TissueRegeneration #OrganRegeneration #RegenerativeMedicine #CellTherapy #Allogeneic #Aging #Longevity
-
LyGenesis uses the lymph node's evolutionary function to serve as an efficient and rapid bioreactor for T-cells to help fight infection and to help vascularize our allogenic cell therapies, a key barrier to the successful clinical application of many other cell therapies. #drugdevelopment #drugresearch #organdonor #liverdisease #liverfailure #science
-
This clip of our CEO Michael Hufford speaking at Abundance 360 encapsulates the core of Lygenesis. Make sure to watch the video below! #liverfailure #organtransplant #drugdevelopment #biotech #investment #organdonor #science #TissueRegeneration #OrganRegeneration #RegenerativeMedicine #CellTherapy #Allogeneic #Aging #Longevity